Visalytics
Visalytics
approved EB-2 (NIW)

Principal Biomarker Statistician

Bioinformatics · China · 2025-03-04

Processing Time
53 days
Decision Date
2025-03-04
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research on developing and applying advanced statistical and machine learning models for analyzing multi-omics data. This work aims to advance the development of mRNA cancer immunotherapies for treating melanoma, non-small cell lung cancer, and other solid cancers.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor was found to have significant value for U.S. technological leadership and the advancement of cancer immunotherapies.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record, and 62 citations demonstrate that other researchers consistently look to her findings to guide their studies.

3 On Balance, Beneficial to Waive Job Offer Met

The petitioner's NIH-funded research and specialized expertise in multi-omics data analysis make her contributions deeply important to the nation's health interests.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in bioinformatics and her record of 5 peer-reviewed journal articles, 1 conference article, and 3 abstracts which garnered 62 citations. The case was supported by 3 expert recommendation letters and evidence of funding from the National Institutes of Health (NIH), satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
California 612 days 2025-08-21
The petitioner proposes to build bioinformatics tools to uncover mechanisms driving cancer development and progression. Her work integrates single-cell analysis, transcriptomics, and machine learning to improve therapeutic strategies and inform precision medicine. The endeavor aims to reduce the national burden of cancer and enhance drug discovery efforts.
View Case

Data Scientist

Biotechnology

WeGreened EB-2 (NIW) approved
71 days 2025-01-04
The petitioner proposes to interrogate multimodal genomic and clinical datasets from cancer patients to uncover key associations between genetic traits, clinical features, and therapeutic responses. This work aims to enable the development of individualized cancer treatment strategies and reduce the financial and human burden of cancer in the U.S.
View Case

Scientist

Biotechnology · Nepal

WeGreened EB-2 (NIW) approved
Massachusetts 47 days 2025-02-06
The petitioner proposes to continue research in cancer precision medicine by leveraging omics-based data, including genomic, transcriptomic, and proteomic analyses. The work focuses on identifying clinically actionable biomarkers to develop personalized therapies and improve patient outcomes for those with cancer.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 289 days 2025-02-26
The petitioner proposes to continue her research in biotechnology, specifically developing novel combinatorial chemotherapies, immunotherapies, and plasma-based prognostic markers for cancer treatment. Her work focuses on investigating cancer signaling pathways and immune checkpoint regulation to enhance therapeutic efficacy and support personalized oncology care.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-04.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 53 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist